merged_abortion-pill-ella.txt
<question_number>1</question_number>
<answer>60 milligram dose of ulipristal acetate</answer>
<other>This is based on the study's use of ulipristal acetate at double the dose of Ella, which is the focus of the legal challenge.</other>
<question_number>2</question_number>
<answer>misoprostol</answer>
<other>The experimental regimen and the standard two-drug regimen both use misoprostol, which could be targeted similarly to how the Texas attorney general targeted mailing abortion pills.</other>
<question_number>3</question_number>
<answer>progesterone</answer>
<other>Both mifepristone and ulipristal acetate target progesterone, which is crucial for maintaining pregnancy.</other>
<question_number>4</question_number>
<answer>implantation</answer>
<other>Despite recent studies suggesting otherwise, plaintiffs would likely claim that the medication affects implantation, similar to the FDA's past stance on Plan B.</other>
<question_number>5</question_number>
<answer>mifepristone</answer>
<other>Mifepristone, approved for use up to 12 weeks' gestation, would have its availability indirectly impacted by actions taken against ulipristal acetate.</other>
<question_number>6</question_number>
<answer>Affordable Care Act's required insurance coverage of contraception</answer>
<other>Project 2025 seeks to remove Ella from the Affordable Care Act's required coverage, which would be the focus of a lawsuit based on the study's findings.</other>
<question_number>7</question_number>
<answer>Plan B One-Step</answer>
<other>Plan B One-Step would remain unaffected by legal restrictions targeting ulipristal acetate, despite sharing a similar mechanism of action according to some abortion opponents.</other>
<question_number>8</question_number>
<answer>misoprostol</answer>
<other>The lawsuit would most likely not directly target misoprostol, despite its role in terminating the pregnancy, as it has various medical uses and is not as targeted by abortion opponents as mifepristone or ulipristal acetate.</other>